1. Altshuler L, Kiriakos L, Calcagno J, et al. The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: a retrospective chart review. J Clin Psychiatry 2001;62:612-16.
2. Altshuler L, Suppes T, Black D, et al. Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up. Am J Psychiatry 2003;160:1252-62.
3. Ghaemi S, El-Mallakh R, Baldassano CF, et al. Antidepressant treatment in bipolar depression: Long-term outcome (abstract). San Juan, PR: American College of Neuropsychopharmacology annual meeting, 2003.
4. Sachs GS. Mood stabilizers alone vs.mood stabilizers plus antidepressant in bipolar depression (symposium). San Juan, PR: American College of Neuropsychopharmacology annual meeting, 2003.
5. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-88.
6. Tohen M, Vieta E, Ketter TA, et al. Acute and long-term efficacy of olanzapine and olanzapine/fluoxetine combination for bipolar depression (abstract). San Juan, PR: American College of Neuropsychopharmacology annual meeting, 2003.
7. Calabrese JR, Macfadden W, McCoy R, et al. Double-blind, placebo-controlled study of quetiapine in bipolar depression (abstract). New York: American Psychiatric Association annual meeting, 2004.
8. Post RM, Denicoff KD, Leverich GS, et al. Presentations of depression in bipolar illness. Clin Neurosci Res 2002a;2:142-57.
9. Post RM, Leverich GS, Nolen WA, et al. A re-evaluation of the role of antidepressants in the treatment of bipolar depression: data from the Stanley Bipolar Treatment Network. Bipolar Disord 2003a;5:396-406.
10. Post RM, Speer AM, Leverich GS. Bipolar illness: Which critical treatment issues need studying? Clinical Approaches in Bipolar Disorders 2003b;2:24-30.
11. Goodwin GM. Bipolar disorder: is psychiatry’s Cinderella starting to get out a little more? Acta Neuropsychiatry 2000;12:105.-
12. Leverich GS, Post RM. Life charting the course of bipolar disorder. Current Review of Mood and Anxiety Disorders 1996;1:48-61.
13. Leverich GS, Post RM. Life charting of affective disorders. CNS Spectrums 1998;3:21-37.
14. Sachs GS, Thase ME, Otto MW, et al. Rationale, design, and methods of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Biol Psychiatry 2003;53:1028-42.
15. Post RM, Speer AM, Obrocea GV, Leverich GS. Acute and prophylactic effects of anticonvulsants in bipolar depression. Clin Neurosci Res 2002;2:228-51.
16. Post RM, Speer AM. A brief history of anticonvulsant use in affective disorders. In: Trimble MR, Schmitz B (eds). Seizures, affective disorders and anticonvulsant drugs Surrey, UK: Clarius Press 2002;53:81.-
17. Post RM, Speer AM, Leverich GS. Complex combination therapy: the evolution toward rational polypharmacy in lithium-resistant bipolar illness, In: Akiskal H, Tohen M (eds). 50 years: the psychopharmacology of bipolar illness London: John Wiley & Sons Ltd. 2004 (in press).
18. Post RM, Altshuler LL. Mood disorders: treatment of bipolar disorders. Sadock BJ, Sadock VA (eds). Kaplan & Sadock’s comprehensive textbook of psychiatry (8th ed) New York: Lippincott Williams & Wilkins, 2004 (in press).
